Age-standardised incidence rates (ASIR) among males, by age group, in the Lahore district, Pakistan, 2010–2012
| Site (males) | Count 0–14 years | ASIR 0–14 years | Count 15–19 years | ASIR 15–19 years | Count ≥20 years | ASIR ≥20 years |
| Lip | 0 | 0.0 | 0 | 0.0 | 13 | 0.2 |
| Tongue | 0 | 0.0 | 0 | 0.0 | 180 | 3.0 |
| Mouth | 2 | 0.0 | 0 | 0.0 | 210 | 3.6 |
| Salivary glands | 2 | 0.0 | 1 | 0.1 | 47 | 0.8 |
| Tonsil | 0 | 0.0 | 0 | 0.0 | 8 | 0.1 |
| Other oropharynx | 0 | 0.0 | 0 | 0.0 | 6 | 0.1 |
| Nasopharynx | 0 | 0.0 | 2 | 0.1 | 17 | 0.3 |
| Hypopharynx | 0 | 0.0 | 0 | 0.0 | 21 | 0.4 |
| Pharynx | 0 | 0.0 | 0 | 0.0 | 5 | 0.1 |
| Oesophagus | 0 | 0.0 | 1 | 0.1 | 126 | 2.3 |
| Stomach | 1 | 0.0 | 0 | 0.0 | 161 | 2.7 |
| Small intestine | 0 | 0.0 | 0 | 0.0 | 26 | 0.4 |
| Colon | 1 | 0.0 | 7 | 0.4 | 222 | 3.9 |
| Rectum | 0 | 0.0 | 7 | 0.4 | 179 | 3.0 |
| Anus | 0 | 0.0 | 2 | 0.1 | 39 | 0.6 |
| Liver | 1 | 0.0 | 1 | 0.1 | 326 | 6.1 |
| Gall bladder and so on | 0 | 0.0 | 1 | 0.1 | 92 | 1.7 |
| Pancreas | 0 | 0.0 | 0 | 0.0 | 57 | 1.1 |
| Other ill-defined digestive | 0 | 0.0 | 0 | 0.0 | 16 | 0.3 |
| Nose, sinuses | 1 | 0.0 | 2 | 0.1 | 29 | 0.5 |
| Larynx | 0 | 0.0 | 0 | 0.0 | 183 | 3.4 |
| Trachea, bronchus and lung | 0 | 0.0 | 0 | 0.0 | 396 | 7.7 |
| Other thoracic organs | 2 | 0.0 | 1 | 0.1 | 23 | 0.4 |
| Bone | 38 | 0.6 | 42 | 2.4 | 63 | 0.9 |
| Melanoma of the skin | 1 | 0.0 | 1 | 0.1 | 11 | 0.2 |
| Other skin | 8 | 0.1 | 4 | 0.2 | 259 | 4.6 |
| Connective and soft tissue | 21 | 0.4 | 15 | 0.9 | 108 | 1.6 |
| Breast | 0 | 0.0 | 1 | 0.1 | 69 | 1.3 |
| Penis | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
| Prostate | 0 | 0.0 | 0 | 0.0 | 526 | 10.7 |
| Testis | 4 | 0.1 | 9 | 0.5 | 77 | 0.9 |
| Other male genital organs | 1 | 0.0 | 0 | 0.0 | 4 | 0.1 |
| Kidney | 17 | 0.3 | 2 | 0.1 | 153 | 2.7 |
| Renal pelvis | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
| Ureter | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
| Bladder | 1 | 0.0 | 0 | 0.0 | 440 | 8.4 |
| Other urinary organs | 0 | 0.0 | 0 | 0.0 | 2 | 0.0 |
| Eye | 27 | 0.5 | 2 | 0.1 | 28 | 0.5 |
| Brain, nervous system | 48 | 0.8 | 20 | 1.2 | 390 | 5.8 |
| Thyroid | 1 | 0.0 | 3 | 0.2 | 77 | 1.2 |
| Adrenal | 1 | 0.0 | 1 | 0.1 | 5 | 0.1 |
| Hodgkin lymphoma | 66 | 1.1 | 17 | 1.0 | 119 | 1.7 |
| Non-Hodgkin lymphoma | 58 | 0.9 | 23 | 1.3 | 412 | 6.8 |
| Multiple myeloma | 1 | 0.0 | 0 | 0.0 | 52 | 0.9 |
| Lymphoid leukaemia | 156 | 2.7 | 12 | 0.7 | 39 | 0.6 |
| Myeloid leukaemia | 21 | 0.3 | 7 | 0.4 | 79 | 1.1 |
| Other leukaemias | 0 | 0.0 | 0 | 0.0 | 6 | 0.1 |
| Leukaemia, unspecified | 34 | 0.6 | 3 | 0.2 | 23 | 0.3 |
| Other and unspecified | 21 | 0.3 | 15 | 0.9 | 525 | 9.2 |
| Benign CNS | 19 | 0.3 | 8 | 0.5 | 155 | 2.1 |
| All sites (n (%)) | 554 (8.1%) | 9.3 | 210 (3.1%) | 12.2 | 6007 (88.7%) | 104.5 |
Incidence rates based on fewer than 10 cases are shown in italics following IARC Cancer Incidence in Five Continents (CI5) practice to indicate unstable incidence rates.
CNS, central nervous system .